Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 3 | 2023 | 1234 | 0.690 |
Why?
|
| Heart Arrest | 1 | 2023 | 315 | 0.580 |
Why?
|
| Uvula | 1 | 2018 | 7 | 0.550 |
Why?
|
| Fiber Optic Technology | 1 | 2018 | 32 | 0.550 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 661 | 0.460 |
Why?
|
| Physicians | 1 | 2023 | 685 | 0.460 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 481 | 0.440 |
Why?
|
| Research Design | 2 | 2018 | 651 | 0.430 |
Why?
|
| Positive-Pressure Respiration | 2 | 2019 | 50 | 0.420 |
Why?
|
| Intraoperative Care | 2 | 2019 | 90 | 0.400 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 992 | 0.390 |
Why?
|
| Biomedical Research | 1 | 2018 | 471 | 0.370 |
Why?
|
| Lung Diseases | 2 | 2019 | 284 | 0.350 |
Why?
|
| Surgical Procedures, Operative | 2 | 2019 | 224 | 0.350 |
Why?
|
| Obesity | 2 | 2019 | 1077 | 0.250 |
Why?
|
| Fatty Acids | 1 | 2023 | 145 | 0.190 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2022 | 14 | 0.190 |
Why?
|
| Antigens, Neoplasm | 2 | 2005 | 365 | 0.190 |
Why?
|
| Anesthesia, General | 2 | 2019 | 129 | 0.180 |
Why?
|
| Dysbiosis | 1 | 2023 | 103 | 0.180 |
Why?
|
| Feces | 1 | 2023 | 390 | 0.170 |
Why?
|
| Mast-Cell Sarcoma | 1 | 2000 | 15 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2011 | 701 | 0.150 |
Why?
|
| Trans-Activators | 1 | 2000 | 447 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2019 | 2687 | 0.130 |
Why?
|
| Fluid Therapy | 1 | 2018 | 68 | 0.130 |
Why?
|
| Lung Injury | 1 | 2018 | 61 | 0.130 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 160 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2018 | 196 | 0.110 |
Why?
|
| Heart Transplantation | 1 | 2022 | 874 | 0.110 |
Why?
|
| Respiration, Artificial | 1 | 2018 | 430 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2022 | 942 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2000 | 1186 | 0.100 |
Why?
|
| Humans | 11 | 2023 | 98362 | 0.100 |
Why?
|
| Lymphocyte Subsets | 1 | 2011 | 72 | 0.090 |
Why?
|
| Body Mass Index | 2 | 2019 | 867 | 0.080 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 111 | 0.080 |
Why?
|
| Lung | 1 | 2017 | 1408 | 0.080 |
Why?
|
| Interferon Type I | 1 | 2011 | 170 | 0.080 |
Why?
|
| Pulmonary Atelectasis | 1 | 2019 | 19 | 0.070 |
Why?
|
| Tidal Volume | 1 | 2019 | 62 | 0.070 |
Why?
|
| Pleural Diseases | 1 | 2019 | 15 | 0.070 |
Why?
|
| Coronary Artery Bypass | 1 | 2011 | 231 | 0.070 |
Why?
|
| Neoplasms, Experimental | 2 | 2006 | 263 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 396 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2011 | 552 | 0.060 |
Why?
|
| Melanoma | 1 | 2011 | 524 | 0.060 |
Why?
|
| STAT1 Transcription Factor | 2 | 2011 | 60 | 0.060 |
Why?
|
| Lymphopenia | 1 | 2006 | 31 | 0.060 |
Why?
|
| Respiratory Insufficiency | 1 | 2019 | 204 | 0.060 |
Why?
|
| Clonal Anergy | 1 | 2006 | 32 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 78 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2011 | 2212 | 0.050 |
Why?
|
| Neoplasm Transplantation | 2 | 2005 | 400 | 0.050 |
Why?
|
| Homeostasis | 1 | 2006 | 474 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2006 | 386 | 0.050 |
Why?
|
| Leukemia L1210 | 1 | 2000 | 12 | 0.040 |
Why?
|
| STAT6 Transcription Factor | 1 | 2000 | 32 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2000 | 146 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2019 | 9770 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2011 | 3633 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1791 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2000 | 218 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2000 | 110 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 464 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 1334 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2000 | 321 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 1028 | 0.040 |
Why?
|
| Transfection | 1 | 2000 | 883 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2000 | 291 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2000 | 479 | 0.040 |
Why?
|
| Echocardiography | 1 | 2022 | 784 | 0.030 |
Why?
|
| Mice | 4 | 2011 | 12735 | 0.030 |
Why?
|
| Protective Factors | 1 | 2017 | 30 | 0.030 |
Why?
|
| Liver | 1 | 2022 | 1230 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2017 | 156 | 0.030 |
Why?
|
| Adoptive Transfer | 2 | 2006 | 174 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 1268 | 0.030 |
Why?
|
| Animals | 5 | 2011 | 28981 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2000 | 1647 | 0.030 |
Why?
|
| Female | 3 | 2019 | 51756 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 29587 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 2896 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2006 | 1607 | 0.020 |
Why?
|
| Male | 2 | 2019 | 47257 | 0.020 |
Why?
|
| Neoplasms | 1 | 2006 | 3348 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 520 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 29532 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 860 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 5576 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2011 | 563 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2011 | 482 | 0.020 |
Why?
|
| Genes, RAG-1 | 1 | 2006 | 11 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 11039 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 6271 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 373 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 722 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 117 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 3616 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2006 | 453 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2005 | 234 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 945 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 3269 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 891 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 1094 | 0.010 |
Why?
|